Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

NCT04417530 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Uveal Melanoma
Ocular Melanoma
Choroidal Melanoma

Interventions

DRUG: AU-011
DEVICE: Suprachoroidal Microinjector
DEVICE: PDT Laser

Sponsor

Aura Biosciences